GoodRx Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 195.1 million compared to USD 140.45 million a year ago. Net loss was USD 18.07 million compared to USD 50.03 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.21 a year ago. Diluted loss per share from continuing operations was USD 0.04 compared to USD 0.21 a year ago. For the nine months, sales was USD 532.17 million compared to USD 397.16 million a year ago. Net income was USD 14.66 million compared to USD 4.65 million a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.01 a year ago. Diluted earnings per share from continuing operations was USD 0.03 compared to USD 0.01 a year ago.